Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · IEX Real-Time Price · USD
6.41
+0.11 (1.75%)
At close: May 31, 2024, 4:00 PM
6.55
+0.14 (2.18%)
After-hours: May 31, 2024, 5:13 PM EDT

Relay Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018
Cash & Equivalents
146.44154.37282.7448.5242.83
Upgrade
Short-Term Investments
606.35847.12677.95230.42313.86
Upgrade
Cash & Cash Equivalents
752.791,001960.65678.94356.69
Upgrade
Cash Growth
-24.83%4.25%41.49%90.34%-15.55%
Upgrade
Receivables
00.310.4750
Upgrade
Other Current Assets
17.3117.715.1916.163.84
Upgrade
Total Current Assets
770.11,020976.24770.1360.54
Upgrade
Property, Plant & Equipment
68.8775.3927.3228.8331.65
Upgrade
Goodwill and Intangibles
2.32.32.300
Upgrade
Other Long-Term Assets
2.712.582.580.90.88
Upgrade
Total Long-Term Assets
73.8880.2732.229.7332.53
Upgrade
Total Assets
843.981,1001,008799.83393.07
Upgrade
Accounts Payable
9.2110.588.286.356.99
Upgrade
Deferred Revenue
000.2500
Upgrade
Current Debt
4.964.281.841.521.25
Upgrade
Other Current Liabilities
16.0948.8613.955.763.75
Upgrade
Total Current Liabilities
30.2763.7124.3213.6311.99
Upgrade
Long-Term Debt
48.553.4721.0622.923.58
Upgrade
Other Long-Term Liabilities
13.2132.3865.2600.16
Upgrade
Total Long-Term Liabilities
61.7185.8486.3122.923.74
Upgrade
Total Liabilities
91.98149.55110.6436.5435.73
Upgrade
Total Debt
53.4757.7422.924.4224.83
Upgrade
Debt Growth
-7.41%152.15%-6.23%-1.65%13850.56%
Upgrade
Retained Earnings
-1,400.58-1,058.61-768.1-404.23-189.48
Upgrade
Comprehensive Income
-0.2-10.42-1.090.060.33
Upgrade
Shareholders' Equity
752950.22897.81763.29-180.44
Upgrade
Net Cash / Debt
699.33943.75937.75654.52331.86
Upgrade
Net Cash / Debt Growth
-25.90%0.64%43.27%97.23%-21.40%
Upgrade
Net Cash Per Share
5.718.419.8615.3696.18
Upgrade
Working Capital
739.83955.8951.92756.47348.55
Upgrade
Book Value Per Share
6.138.479.4417.91-52.29
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).